Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Mar 07, 2022 11:24am
Clown Show @ Algernon Pharmaceuticals: Doors Open 24/7/365
(10)
•••
CASHEAGLE
X
View Profile
View Bullboard History
Comment by
CASHEAGLE
on Mar 02, 2022 1:34pm
RE:RE:RE:$2 Million Cash On Hand Makes This A $1.20 Stock @ Best
YOU ARE BIPOLAR AND MENTALLY UNSTABLE HERE IS A POST FROM ONE OF YOUR "UP" DAYS GET SOME HELP GREAT GURU WHO IS EDUCATING THE MASSES +
...more
Debt-Free and Thriving: Mining Company Reports 35% Revenue Growth in Q3 2024
posted Nov 12, 2024 9:00am by
Mandalay Resources Corp.
-
|
"Revenue growth and free cash flow generation reflect our cost controls and prudent capital management while benefitting from high metal prices. As of the end of Q3 our cash balance was a healthy $54.7 million – more than doubling since December 2023 – and we have fully repaid the $20 million outstanding balance on our revolving credit facility, strengthening our liquidity and financial flexibility ...read more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Mar 02, 2022 6:26am
RE:RE:$2 Million Cash On Hand Makes This A $1.20 Stock @ Best
Subjectively the Mona Lisa is said to be worth $850 Million USD. A piece of art I personally wouldn't buy at a garage sell. Objectively, we know AGN stock traded at $2.50 USD. Hence, with
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Mar 02, 2022 4:26am
P & S is back to harass th masses with a thin air boogie man
https://stockhouse.com/companies/bullboard?symbol=c.blo&postid=34473803
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Comment by
nodaytrader
on Feb 28, 2022 1:57pm
RE:$2 Million Cash On Hand Makes This A $1.20 Stock @ Best
And the Mona Lisa is only worth the cost of the paint!
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Feb 28, 2022 9:57am
$2 Million Cash On Hand Makes This A $1.20 Stock @ Best
J U N K ~ S T O C K
(33)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Feb 24, 2022 7:45pm
Update: AGN CEO Chris Moreau Discusses Recent Announcement
News Update: Algernon Pharma (AGN) w CEO Chris Moreau - New Chronic Kidney Disease Research Program - https://www.youtube.com/watch?v=WMYwaTkTs_g Chris discusses recent announcement: Algernon Begins
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Feb 22, 2022 9:57am
When'll The CEO Stop Talking Out Of Both Sides Of His Mouth?
One side of his mouth: "The Company also announces it has appointed Dr. Anthony Rudd and Dr. Robert Simister, both from the U.K., as medical consultants to the Company’s DMT stroke clinical
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Feb 20, 2022 12:22pm
Take A Page From Katy Perry & Get Ur DMT Messaging In Order
Yo management! Nobody knows you're in the psychedelic business. The pennyland circuit could careless what you're up to. Where's the uplist to Nasdaq? The year is starting out to be another
...more
(18)
•••
nodaytrader
X
View Profile
View Bullboard History
Post by
nodaytrader
on Feb 18, 2022 3:20pm
Price Dropping
The price is falling on mini trades led, again, by Integral Wealth Securities. Where do they find these sellers wiilling to sell low?
(22)
•••
GoodLife60
X
View Profile
View Bullboard History
Comment by
GoodLife60
on Feb 14, 2022 7:03pm
RE:RE:Price before Split
Thanks
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Feb 12, 2022 6:18am
CALLING DR. MARK WILLIAMS! CALLING DR. MARK WILLIAMS!
Doc, can you please provide the masses with another BioPub webcast explanation of your mathematical theory of how Ifenprodil has a 65% chance of success at the Phase 2 clinical trial process. I'd
...more
(2)
•••
ChargingStocks
X
View Profile
View Bullboard History
Post by
ChargingStocks
on Feb 08, 2022 10:20am
Interview with Christopher Moreau
Good Morning Check out the latest update on many of the changes at Algernon. https://www.youtube.com/watch?v=o1MoPbSTXuU
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Feb 08, 2022 5:47am
What Can You Do When In 48 Hours...
The United States Federal Reserve Will Announce Interest Rate Hikes In A copule Of Days: {^youtubevideo|(width)480|(height)295|(rel)False|(url)https://www.youtube.com/watch?v=68wP3J8V1ZA|(fs)True
...more
(0)
•••
exipurereview
X
View Profile
View Bullboard History
Post by
exipurereview
on Feb 04, 2022 11:07am
exipure reviews-exipure complaints-exipure bad reviews
exipure reviews-exipure complaints-exipure bad reviews- does exipure really Exipure is an innovative weight loss formula that is currently available online only. It offers users a doctor
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Meet the Top 5 Best Online Brokerages in Canada
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Star Diamond Corporation Announces Third Quarter 2024 Results